J
James J. Collins
Researcher at Massachusetts Institute of Technology
Publications - 700
Citations - 105255
James J. Collins is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Synthetic biology & Population. The author has an hindex of 151, co-authored 669 publications receiving 89476 citations. Previous affiliations of James J. Collins include Baylor College of Medicine & University at Albany, SUNY.
Papers
More filters
Journal ArticleDOI
Controlled movement and suppression of spiral waves in excitable media
TL;DR: It is shown that the controlled drift and subsequent annihilation of a spiral wave can be achieved through the combination of two factors: the introduction of small spatial inhomogeneities in the medium and the interaction of the wave with the boundaries of the medium.
ZSCAN10 expression corrects the genomic instability of iPSCs from aged donors
Maria Skamagki,Cristina Correia,Percy Yeung,Timour Baslan,Samuel Beck,Cheng Zhang,Christian A. Ross,Lam Dang,Zhong Liu,Simona Giunta,Tzu-Pei Chang,Joye Wang,Aparna Ananthanarayanan,Martina Bohndorf,Benedikt Bosbach,James Adjaye,Hironori Funabiki,Jonghwan Kim,Scott W. Lowe,Chi-Wei Lu,Hu Li,Rui Zhao,Kitai Kim,James J. Collins +23 more
Journal ArticleDOI
Selling the Market Educational Standards, Discourse and Social Inequality
TL;DR: The authors analyzes interactional figures and socio-political themes involved in the elite and non-elite discourse of standards, with particular focus on the neo-liberal trope of a new era of work and associated fears of increasing inequality.
Journal ArticleDOI
An engineered live biotherapeutic for the prevention of antibiotic-induced dysbiosis
Andres Cubillos-Ruiz,Miguel A. Alcantar,Nina M. Donghia,Pablo Cárdenas,Julian Avila-Pacheco,James J. Collins +5 more
TL;DR: Oral supplementation with the engineered live biotherapeutic minimized gut dysbiosis without affecting the ampicillin concentration in serum, precluded the enrichment of antimicrobial resistance genes in the gut microbiome and prevented the loss of colonization resistance against Clostridioides difficile.
Journal ArticleDOI
Left ventricular non-compaction cardiomyopathy associated with epidermolysis bullosa simplex with muscular dystrophy and PLEC1 mutation.
Chet R. Villa,Thomas J. Ryan,James J. Collins,Michael D. Taylor,Anne W. Lucky,John L. Jefferies +5 more
TL;DR: The first case of left ventricular non-compaction in an 18-year-old male with epidermolysis bullosa simplex with muscular dystrophy and a PLEC1 mutation is reported.